RBC Bearings INC - 10-Q Summary (Q1 2027)
Business Context and Reporting Period
This filing covers the quarterly period ended June 27, 2026 (First Quarter of Fiscal 2027). RBC Bearings Incorporated is a leading international manufacturer of highly engineered precision bearings and components for the Aerospace & Defense and Industrial sectors. The company operates 66 facilities in 11 countries. The quarter included 13 weeks of operations.
Key Financial Metrics
| Metric | Q1 2027 (Ended June 27, 2026) | Q1 2026 (Ended June 28, 2025) |
|---|---|---|
| Net Sales | $519.5 million | $436.0 million |
| Gross Margin | $247.8 million (47.7%) | $195.2 million (44.8%) |
| Operating Income | $140.8 million | $101.1 million |
| Net Income | $101.5 million | $68.5 million |
| Diluted EPS | $3.20 | $2.17 |
| Operating Cash Flow | $171.8 million | $120.0 million |
| Total Debt (Gross) | $806.2 million | $875.5 million |
| Cash and Equivalents | $124.5 million | $132.9 million |
| Backlog | $2.3 billion | $1.0 billion |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 19.2% year-over-year, driven by a 36.9% surge in the Aerospace & Defense segment and an 8.4% increase in the Industrial segment.
- Profitability: Net income rose 48.2% to $101.5 million. Gross margin expanded 290 basis points to 47.7%, aided by operational efficiencies, favorable product mix, and temporary tariff refund benefits.
- Acquisition Impact: The acquisition of VACCO (closed July 2025) contributed $31.7 million to Defense sales and $1.6 million to Commercial Aerospace sales in this quarter.
- Debt Reduction: Total debt decreased by approximately $69.3 million compared to the prior year-end, primarily due to term loan repayments. Subsequent to the quarter end, the company paid down an additional $50.0 million on the Term Loan.
- Capital Expenditures: Increased to $24.9 million from $15.7 million in the prior year period, reflecting facility expansions and growth investments.
Guidance, Outlook, and Risks
- Q2 Guidance: Management expects Q2 2027 net sales to be between $505.0 million and $515.0 million, representing a 10.9% to 13.1% increase over Q2 2026.
- Outlook: Commercial aerospace growth is expected to continue as build rates escalate. Defense sales are projected to grow as the company fulfills a substantial backlog. Industrial markets remain strong in semicon, grain, and food/beverage sectors.
- Liquidity: The company maintains a $500.0 million Revolving Credit Facility (extended to 2030) with $296.3 million available. Management believes operating cash flows and credit facilities are sufficient for the next 12 months.
- Risks: Key risks include cyclical end markets, supply chain constraints, raw material costs, trade tariffs, and the integration of recent acquisitions. Foreign currency fluctuations remain a factor, though hedging strategies (Cross Currency Swap) are in place.
Investor Verification Checklist
- Verify the sustainability of the 47.7% gross margin, specifically the impact of temporary tariff refunds mentioned in the MD&A.
- Confirm the integration progress and revenue contribution of the VACCO acquisition in subsequent quarters.
- Monitor the Term Loan maturity (November 2026) and the company's ability to refinance or pay down the remaining balance given the recent $50M post-quarter paydown.
- Assess the backlog conversion rate, noting the significant increase to $2.3 billion compared to $1.0 billion a year ago.
- Review the impact of foreign currency translation on future earnings, as the USD strengthened against the CHF during the quarter.